Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma

被引:0
|
作者
Keiichi Koshizuka
Toyoyuki Hanazawa
Takayuki Arai
Atsushi Okato
Naoko Kikkawa
Naohiko Seki
机构
[1] Chiba University Graduate School of Medicine,Department of Functional Genomics
[2] Chiba University Graduate School of Medicine,Department of Otorhinolaryngology/Head and Neck Surgery
来源
关键词
microRNA; Head and neck squamous cell carcinoma; Expression signature; Antitumor;
D O I
暂无
中图分类号
学科分类号
摘要
MicroRNAs (miRNAs) are small noncoding RNAs that act as fine-tuners of the post-transcriptional control of protein-coding or noncoding RNAs by repressing translation or cleaving RNA transcripts in a sequence-dependent manner in cells. Accumulating evidence have been indicated that aberrantly expressed miRNAs are deeply involved in human pathogenesis, including cancers. Surprisingly, these small, single-stranded RNAs (18–23 nucleotides) have been shown to function as antitumor or oncogenic RNAs in several types of cancer cells. A single miRNA has regulating hundreds or thousands of different mRNAs, and individual mRNA has been regulated by multiple different miRNAs in normal cells. Therefore, tightly controlled RNA networks can be disrupted by dysregulated of miRNAs in cancer cells. Investigation of novel miRNA-mediated RNA networks in cancer cells could provide new insights in the field of cancer research. In this review, we focus on head and neck squamous cell carcinoma (HNSCC) and discuss current findings of the involvement of aberrantly expressed miRNAs in the pathogenesis of HNSCC.
引用
收藏
页码:525 / 545
页数:20
相关论文
共 50 条
  • [41] Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma
    Ana Carolina de Carvalho
    Cristovam Scapulatempo-Neto
    Danielle Calheiros Campelo Maia
    Adriane Feijó Evangelista
    Mariana Andozia Morini
    André Lopes Carvalho
    André Luiz Vettore
    BMC Medicine, 13
  • [42] The prognostic value of MicroRNAs associated with fatty acid metabolism in head and neck squamous cell carcinoma
    Wang, Xiaojing
    Zhao, Yue
    Strohmer, Dorothee Franziska
    Yang, Wenjin
    Xia, Zhijia
    Yu, Cong
    FRONTIERS IN GENETICS, 2022, 13
  • [43] MicroRNAs Expression Model Predicts Time to Local Recurrence in Head and Neck Squamous Cell Carcinoma
    Hermanova, Marketa
    Ahmad, Parwez
    Sana, Jiri
    Slavik, Marek
    Shatokhina, Tetiana
    Slaby, Ondrej
    LABORATORY INVESTIGATION, 2018, 98 : 476 - 476
  • [44] MicroRNAs Expression Model Predicts Time to Local Recurrence in Head and Neck Squamous Cell Carcinoma
    Hermanova, Marketa
    Ahmad, Parwez
    Sana, Jiri
    Slavik, Marek
    Shatokhina, Tetiana
    Slaby, Ondrej
    MODERN PATHOLOGY, 2018, 31 : 476 - 476
  • [45] MicroRNAs: Their Role in Metabolism, Tumor Microenvironment, and Therapeutic Implications in Head and Neck Squamous Cell Carcinoma
    Shiah, Shine-Gwo
    Chou, Sung-Tau
    Chang, Jang-Yang
    CANCERS, 2021, 13 (22)
  • [46] Biomarkers of squamous cell carcinoma of the head and neck
    Kim, J
    Shin, DM
    HISTOLOGY AND HISTOPATHOLOGY, 1997, 12 (01) : 205 - 218
  • [47] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Moskovitz, Jessica
    Moy, Jennifer
    Ferris, Robert L.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (02)
  • [49] Afatinib in squamous cell carcinoma of the head and neck
    Specenier, Pol
    Vermorken, Jan
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1295 - 1301
  • [50] Docetaxel and squamous cell carcinoma of the head and neck
    Calais, G
    BULLETIN DU CANCER, 2004, 91 (02) : 167 - 171